The shortage of primary care doctors is a national problem. To cope, a large health system in Massachusetts is using an AI tool to screen patients and refer them to other care.
Figuring out the insurance options for families often falls to women. Some say they're delaying marriage, taking side jobs, and putting their kids on Medicaid as premium prices shoot up in 2026.
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.
The Trump administration says it is making deals with drug companies to lower prices U.S. consumers pay for medicines. But key details are missing on how the initiative would work.
The GOP said its overhaul of Medicaid was aimed at reducing fraud and getting more adult beneficiaries to work. Among the likely side effects: fewer services and doctors for treating sick children.
Independent and rural hospitals are collaborating with their neighbors to shore up their finances instead of joining larger health systems to stay afloat.
Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.
In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in the Biden administration continues.
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
